![]() |
Radioimmunotherapy: Safety Measures During Therapy
|
![]() |
The Gene Chip: The Future of Lymphoma Diagnosis?
|
![]() |
Uniting in Hope: Lymphoma Educational Forum Highlights
|
![]() |
Life With Non-Hodgkin's Lymphoma: One Woman's Story
|
![]() |
A New Way to Attack NHL
|
![]() |
What are the Different Types of Non-Hodgkin's Lymphoma?
|
![]() |
What is Non-Hodgkin's Lymphoma?
|
![]() |
Starting Targeted Therapy For Lymphoma: What Are The Options?
|
![]() |
Testing Vaccines for Non-Hodgkin's Lymphoma
|
![]() |
NHL: A Survivor's Journey
|
![]() |
Attacking NHL Early
|
![]() |
Radioimmunotherapy for Non-Hodgkin's Lymphoma
|
![]() |
Measuring Success with Targeted Therapy for NHL
|
![]() |
Radioimmunotherapy for Lymphoma: When Should It Be Used?
|
![]() |
Targeted Therapy for NHL
|
|
|
, Robert O. Dillman M.D., F.A., Eli Gladstein MD, Leo I. Gordon MD, Carol L. Kornmehl MD, FACRO
The aim of radiation therapy is to defeat cancer cells. Radiation can be delivered from a beam located outside the body, or by targeted medications called radioimmunotherapy. The choice of therapies will depend on the characteristics and type of tumor. Learn the differences between the conventional type of radiation and radioimmunotherapy.
ANNOUNCER: Over the years, cancer treatments have tried to get "smarter" by attempting to more precisely target cancer cells. Radiation therapy using an external beam is one answer.
LEO GORDON, MD: The beam is aimed at a certain area of the body. Because the body can only tolerate so much radiation, that beam has to be fairly toned down, fairly direct. So if you have a large tumor in the lung, for example, or under the arm, or in the breast, that radiation can be very effective. It can make the tumor shrink down very well.
ANNOUNCER: However there are some cancers that are hard to fight with this type of therapy, like non-Hodgkins lymphoma, or NHL.
LEO GORDON, MD: It's in multiple locations. So because you can't target external beam radiation to multiple locations, you wouldn't know when to stop and you would wind up with total body radiation, external beam radiation has limited utility, I think, in non-Hodgkin's lymphoma.
ANNOUNCER: But now science has developed an even more targeted form of radiation through a treatment called radioimmunotherapy. NHL is the first type of cancer to be treated with this therapy, using a medicine called Zevalin. In radioimmunotherapy, radiation is linked to antibodies. Typically your immune system uses antibodies to circulate through the bloodstream and attack foreign substances. Like a medical missile, these radioactive antibodies head through the bloodstream to the tumor areas where they attach to cancer cells and destroy them.
LEO GORDON, MD: Radioimmunotherapy takes advantage of the fact that we already have antibodies, which we can target to malignant cells. Radioimmunotherapy adds to that by attaching radioactive particles or radioactive substances to that antibody.
ANNOUNCER: While both external beam therapy and radioimmunotherapy treatments are powerful tools, the nature of the illness will dictate which is the best weapon.
LEO GORDON, MD: If you've got a single large mass that's causing obstruction or symptoms, I think that's a nice role for external beam radiation. If you have multiple masses, multiple tumors, you can't treat them all with external beam radiation. That would be a circumstance where I think radioimmunotherapy would be most effective.
ANNOUNCER: These two therapies differ in the kinds of radiation they use.
ELI GLADSTEIN, MD: External beam therapy refers to a machine that produces radiation. It produces x-rays of very high energy such that they can penetrate tissue.
LEO GORDON, MD: Radioimmunotherapy, the radionuclide has sort of built-in properties where they're either what we call, gamma radiation, such as radioactive iodine, or beta radiation, such as yttrium-90.
ANNOUNCER: Conventional radiation therapy is delivered with an external beam over an extended time, while the radiation in radioimmunotherapy is delivered through the vein over a much shorter time.
LEO GORDON, MD: With radioimmunotherapy, they come once for the tracer and one week later for the treatment dose.
ELI GLADSTEIN, MD: Typically, external beam therapy means that the patient will lie under the machine on a daily basis for 10, 15, 20, sometimes as many as 35 to 40 treatments, days. And each of those treatments may be a couple minutes. With the radiation, external beam radiation, the patient will be irradiated and then have essentially a day to recuperate, and then you repeat the process.
ANNOUNCER: Conventional radiation can be effective, but sometimes there are side effects.
ELI GLADSTEIN, MD: It depends where you're aiming the beam. If you're aiming at the upper abdomen, you might get nausea and vomiting.